BlossomHill Therapeutics, Inc. insider trading
BLSM$19.69+1.10 (+5.92%)
“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.”
Insider Trading vs Stock Price
Insider Trading vs Stock Price data
Showing the 1Y range: Aug 7, 2026 to Oct 2, 2026. Price (+23.1%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.
| Date | Category | Person | Role | Action | Amount | Change in holding |
|---|
Open market purchase
Open market sellNet dollar flow · Buy / Sell balance
PremiumQ2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Unlock quarterly net flowKey players
- YLYishan LiNot reported
- JJJingrong Jean CuiNot reported
- CLCarl L. GordonNot reported
- SASundeep AgrawalNot reported
- VPVincent Paul LiptakNot reported
- SGSheila GujrathiNot reported
- GRGeoffrey Raymond OxnardNot reported
- JPJohn P. SchmidNot reported
- JAJason A. KeyesNot reported
- OAOrbimed Advisors LLCNot reported
AI Activity Analysis
PremiumComing soon
Insider activity
Fromto
| Company | Insider / role | Action | ΔOwn | Avg price | Amount | ||
|---|---|---|---|---|---|---|---|
| BLSM | Carl L. Gordon | Open market purchase$10M | +29.9% | $16.00 | $10M | Aug 10, 2026 | Aug 12, 2026 |
| BLSM | Orbimed Advisors LLC | Open market purchase$10M | +29.9% | $16.00 | $10M | Aug 10, 2026 | Aug 12, 2026 |
| BLSM | Vincent Paul Liptak | Open market purchase$35.2K | +1.7% | $16.00 | $35.2K | Aug 10, 2026 | Aug 10, 2026 |
| BLSM | Jason A. Keyes | Open market purchase$11.2K | Not reported | $16.00 | $11.2K | Aug 10, 2026 | Aug 10, 2026 |
| BLSM | John P. Schmid | Open market purchase$96K | Not reported | $16.00 | $96K | Aug 10, 2026 | Aug 10, 2026 |
| BLSM | Bihua Chen | Open market purchase$5M | +9.5% | $16.00 | $5M | Aug 10, 2026 | Aug 10, 2026 |
| BLSM | Vincent Paul Liptak | Open market purchase$39.5K | +1.9% | $15.80 | $39.5K | Aug 7, 2026 | Aug 10, 2026 |